New York, New York-- (Newsfile Corp. - April 1, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., Inc. (NYSE: MRK) between February 3, ...

U.S. Attorney General Pam Bondi said she has directed prosecutors to seek the death penalty against Luigi Mangione in the ...

Duke Energy Corp. (NYSE: DUK) officially has a new CEO. Harry Sideris ascended to the role today after serving as the company ...

AstraZeneca’s new cholesterol pill is showing promise, while the FTC urged a potential buyer of 23andMe to protect user data.

Already reeling from years of market chaos, the announced departure of CBER chief Peter Marks sent a ripple across biopharma ...

COPENHAGEN, Denmark, April 1, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business ...

With the CSF-1R inhibitor space heating up, Germany's Merck Group has gone all-in on pimicotinib, paying Abbisko Therapeutics ...

The biotech, which has raised more than $140 million over several investment rounds in the last few years from the likes of ...

Pat Geraghty, the longtime top executive of one of the nation’s fastest-growing health insurance companies in Florida Blue, ...

The announcement by NYU Langone’s Board of Trustees was praised by Kenneth Langone, board chair and co-chair of the search ...